Biotech · Private company · Sturgis, MI, US
Maggie's Pearl, LLC
Track this companyFree. Adds Maggie's Pearl, LLC to your Dealase workspace and tells you when its record changes.
Clinical trials10 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline1
- EpalrestatPhase 3 · Pmm2-CDGClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- Oral Epalrestat Therapy in Pediatric Subjects With PMM2-CDGPHASE3 · TERMINATED · started Nov 10, 2022ClinicalTrials.gov NCT04925960 · fetched Nov 12, 2026
NIH awards1
- Targeting aldose reductase: A Phase IIb/III trial for the novel use of Epalrestat to treat Congenital Disorders of Glycosylation (PMM2-CDG)Fiscal year 2024 · $553.1KNIH RePORTER 5R44DK131708-03 · fetched Nov 12, 2026